This week's roundup of Houston innovators includes Dorit Donoviel of TRISH, Nuri Firat Ince of UH, and Vanessa Wade of Connect the Dots. Courtesy photos

Editor's note: In this week's roundup of Houston innovators to know, I'm introducing you to three local innovators across industries — from space to engineering — recently making headlines in Houston innovation.


Dorit Donoviel, director of the Translational Research Institute for Space Health

Dorit Donoviel, director of the Translational Research Institute for Space Health

The new program will work with commercial spaceflight crews to bring back crucial research to one database. Photo via Libby Neder Photography

The Translational Research Institute for Space Health, or TRISH, at Baylor College of Medicine announced a unique program that will work with commercial spaceflight providers and their passengers. The EXPAND — Enhancing eXploration Platforms and Analog Definition — Program will collect information and data from multiple space flights and organize it in one place. TRISH selected TrialX to build the centralized database.

"The space environment causes rapid body changes. This can help us understand how we humans react to and overcome stress. Ensuring that space explorers remain healthy pushes us to invent new approaches for early detection and prevention of medical conditions," says Dorit Donoviel, executive director at TRISH, in the release.

"Studying a broad range of people in space increases our knowledge of human biology. TRISH's EXPAND program will leverage opportunities with commercial spaceflight providers and their willing crew to open up new research horizons." Click here to read more.

Nuri Firat Ince, associate professor of biomedical engineering at UH

A medical device designed by a UH professor will close the loop with high frequency brain waves to prevent seizures from occurring. Photo via uh.edu

Nuri Firat Ince, an associate professor of biomedical engineering at UH, has received a federal grant aimed at helping stop epileptic seizures before they start. The BRAIN Initiative at the National Institute of Neurological Disorders and Stroke awarded the $3.7 million grant to go toward Ince's work to create a seizure-halting device based on his research.

According to UH, Ince has reduced by weeks the time it takes to locate the seizure onset zone (SOZ), the part of the brain that causes seizures in patients with epilepsy. He's done this by detecting high-frequency oscillations (HFO) forming "repetitive waveform patterns" that identify their location in the SOZ.

"If the outcomes of our research in acute settings become successful, we will execute a clinical trial and run our methods with the implanted … system in a chronic ambulatory setting," Ince says. Click here to read more.

Vanessa Wade, founder and owner of Connect the Dots

It's time for large corporations to step up to support small businesses founded by people of color. Photo courtesy

In her guest column for InnovationMap, Vanessa Wade addressed some of the challenges she faced founding a company as a person of color — specifically the lack of access to funding. In the article, she calls corporations to action to help business leaders like herself.

"The journey ahead can feel discouraging, but the good news is that now I have a much better idea of what it will take to build an equitable road back and get businesses like mine on even footing," she writes. Click here to read more.

It's time for large corporations to step up to support small businesses founded by people of color. Photo via Getty Images

Houston expert: Corporations can help level the playing field for BIPOC-owned businesses

Guest column

There were times when I wasn't sure what to do next.

When I started Connect the Dots PR in 2012, I wrote out detailed business plans, saved startup dollars, and leaned heavily on people in the PR industry to guide me in terms of pricing and feedback. Of course, we had contingency plans for unexpected hardships, but you hope not to use them.

My contingency plans went out the window when we saw we were looking at more than a year of pandemic-related shutdowns and slowdowns. I didn't have time to wait it out or say let's see what happens. It was time to move strategically.

Like most businesses, we hit a snag. A big chunk of our client base was reeling with corporate layoffs, shutdowns and revamped budgets. We've held on, but at times, it was overwhelming. I remember when the pandemic initially shut everything down, my fear was what is going to happen to my business and those that depend on me, such as employees, vendors, clients and contractors? At the onset of the pandemic, an employee came to me and said if I needed to let them go they understood. It hurt to do so, but it was a mutual decision and he landed on his feet and relocated to another state.

For a business owner of color, the hurdles are higher. When building Connect the Dots PR, the most important driver was access to startup capital. But studies have shown that white entrepreneurs are able to contribute considerably more personal equity to their new businesses than entrepreneurs of color, because white American families have nearly 10 times as much wealth as Hispanic or Black American families.

While inequities existed before the pandemic, over the last year, they've gotten worse. Beyond the physical toll of COVID-19, which affected BIPOC (Black, Indigenous, People of Color) communities, which includes Hispanic and Asian American communities among others, more severely than white ones, BIPOC-owned businesses have had less of a safety net to fall back on, have been more likely to close, and have had a harder time getting Paycheck Protection Program loans. Studies last summer showed that the pandemic shuttered Black-owned businesses at more than double the rate of white-owned businesses. It all leads to the deeply unequal recovery that we're just now embarking upon.

The journey ahead can feel discouraging, but the good news is that now I have a much better idea of what it will take to build an equitable road back and get businesses like mine on even footing.

First and foremost, there needs to be an investment in people of color-owned businesses from the public, private and nonprofit sectors. Six months ago, I applied to the Comcast RISE program which, since late last year, has invested in 2,500 BIPOC-owned businesses nationwide with monetary grants, technology makeovers and marketing services. I received the Comcast RISE Investment Fund for Connect the Dots PR, which provided relief when it was most needed. With this grant, I have been able to focus on the business and invest in my brand.

We're not the only ones. Comcast RISE plans to name 13,000 recipients by 2022. Houston was also one of five cities selected to award a $10,000 grant to 100 local businesses from the Comcast RISE Investment Fund, which is the grant I received. We need similar commitments from other corporations to level the playing field for people of color business owners.

Federal, state and local recovery programs need to target minority entrepreneurs. Too many of the existing relief efforts have had limited application windows or been first-come-first-served, which disadvantages businesses that are already starting from behind. Local organizations like the Greater Houston Black Chamber of Commerce can be useful allies in reaching businesses owned by historically disadvantaged groups.

Finally, financial institutions need better guardrails to ensure that they don't discriminate against nonwhite business owners. When accessing startup capital, barriers still exist for minority entrepreneurs, and keeping checks and balances on those with the balance sheets is the only way to make sure all businesses are starting on equal footing.

That way, when the next crisis hits, you'll have fewer businesses starting from behind, and we'll all find our way to recovery much faster. For all of us, that's a business plan worth holding onto.

------

Vanessa Wade, is the founder and owner of Houston-based PR firm Connect the Dots.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Axiom Space-tested cancer drug advances to clinical trials

mission critical

A cancer-fighting drug tested aboard several Axiom Space missions is moving forward to clinical trials.

Rebecsinib, which targets a cancer cloning and immune evasion gene, ADAR1, has received FDA approval to enter clinical trials under active Investigational New Drug (IND) status, according to a news release. The drug was tested aboard Axiom Mission 2 (Ax-2) and Axiom Mission 3 (Ax-3). It was developed by Aspera Biomedicine, led by Dr. Catriona Jamieson, director of the UC San Diego Sanford Stem Cell Institute (SSCI).

The San Diego-based Aspera team and Houston-based Axiom partnered to allow Rebecsinib to be tested in microgravity. Tumors have been shown to grow more rapidly in microgravity and even mimic how aggressive cancers can develop in patients.

“In terms of tumor growth, we see a doubling in growth of these little mini-tumors in just 10 days,” Jamieson explained in the release.

Rebecsinib took part in the patient-derived tumor organoid testing aboard the International Space Station. Similar testing is planned to continue on Axiom Station, the company's commercial space station that's currently under development.

Additionally, the drug will be tested aboard Ax-4 under its active IND status, which was targeted to launch June 25.

“We anticipate that this monumental mission will inform the expanded development of the first ADAR1 inhibitory cancer stem cell targeting drug for a broad array of cancers," Jamieson added.

According to Axiom, the milestone represents the potential for commercial space collaborations.

“We’re proud to work with Aspera Biomedicines and the UC San Diego Sanford Stem Cell Institute, as together we have achieved a historic milestone, and we’re even more excited for what’s to come,” Tejpaul Bhatia, the new CEO of Axiom Space, said in the release. “This is how we crack the code of the space economy – uniting public and private partners to turn microgravity into a launchpad for breakthroughs.”